Jeffrey Cummings
Orthopaedic Surgery · Carson City, NVNPI 1740271238
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Alnylam Pharmaceuticals Inc. at 39.7% of the total. Reporting peaked in 2021 at $10,137 and has fallen 63.6% since, to $3,686 in 2025.
Across 51 payments — averaging $493.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alnylam Pharmaceuticals Inc.$10K
- Acadia Pharmaceuticals Inc$6K
- Eisai Inc.$5K
- Sanofi US Services Inc.$2K
- H. Lundbeck A S$835
- Stryker$462
- plus $708 from 13 others
Across 7 payments — averaging $3314.85 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$20K
- F. Hoffmann-la Roche AG$3K
What the payments were for
- Consulting fees$10,99344%
- Speaking & faculty fees$12,00048%
- Travel & lodging$1,1535%
- Food & beverage$1,0404%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $10,000 |
| Acadia Pharmaceuticals Inc | 3 | $6,010 |
| Eisai Inc. | 11 | $5,188 |
| Sanofi US Services Inc. | 2 | $1,983 |
| H. Lundbeck A S | 2 | $835 |
| Stryker | 5 | $462 |
| Zimmer Biomet | 3 | $122 |
| Vericel Corporation | 6 | $103 |
| Steelhead Surgical Inc | 1 | $91 |
| Johnson & Johnson | 2 | $85 |
| Amgen | 4 | $64 |
| Pacira Therapeutics, Inc. | 4 | $58 |
| Arthrex | 1 | $51 |
| Merck | 1 | $45 |
| Bioventus LLC | 1 | $30 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,187 in reported general payments places this provider in the 80th percentile of 135 orthopaedic surgery providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $119 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $57 |
| Meloxicam | 14 | $27 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Carson City
- Rueben NairCarson City$29K
- Marco MendozaCarson City$11K
- Nicholas DirigCarson City$9K
- Mark BarryLas Vegas$9.5M
- Erik KubiakLas Vegas$7.8M
- Russell NevinsLas Vegas$1.5M
- Vladimir SinkovLas Vegas$434K
- Robert TaitHenderson$365K
- Ronald HillockLas Vegas$275K
- Galen KamLas Vegas$270K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.